BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Houston BL, Uminski K, Mutter T, Rimmer E, Houston DS, Menard CE, Garland A, Ariano R, Tinmouth A, Abou-setta AM, Rabbani R, Neilson C, Rochwerg B, Turgeon AF, Falk J, Breau RH, Fergusson DA, Zarychanski R. Efficacy and Safety of Tranexamic Acid in Major Non-Cardiac Surgeries at High Risk for Transfusion: A Systematic Review and Meta-Analysis. Transfusion Medicine Reviews 2020;34:51-62. [DOI: 10.1016/j.tmrv.2019.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Myckatyn TM, Tenenbaum MM. Discussion: Intravenous Tranexamic Acid in Implant-Based Breast Reconstruction Safely Reduces Hematoma without Thromboembolic Events. Plast Reconstr Surg 2020;146:246-7. [PMID: 32740568 DOI: 10.1097/PRS.0000000000006975] [Reference Citation Analysis]
2 Blankstein AR, Houston BL, Fergusson DA, Houston DS, Rimmer E, Bohm E, Aziz M, Garland A, Doucette S, Balshaw R, Turgeon A, Zarychanski R. Transfusion in orthopaedic surgery : a retrospective multicentre cohort study. Bone Jt Open 2021;2:850-7. [PMID: 34665003 DOI: 10.1302/2633-1462.210.BJO-2021-0077.R1] [Reference Citation Analysis]
3 Houston BL, Fergusson DA, Falk J, Krupka E, Perelman I, Breau RH, McIsaac DI, Rimmer E, Houston DS, Garland A, Ariano RE, Tinmouth A, Balshaw R, Turgeon AF, Jacobsohn E, Park J, Buduhan G, Johnson M, Koulack J, Zarychanski R. Evaluation of Transfusion Practices in Noncardiac Surgeries at High Risk for Red Blood Cell Transfusion: A Retrospective Cohort Study. Transfus Med Rev 2021;35:16-21. [PMID: 32994103 DOI: 10.1016/j.tmrv.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cai Y, Ding Z, Rong X, Zhou ZK. Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty? BMC Musculoskelet Disord 2021;22:457. [PMID: 34011340 DOI: 10.1186/s12891-021-04316-3] [Reference Citation Analysis]
5 Ijaopo EO, Ijaopo RO, Adjei S. Bilateral pulmonary embolism while receiving tranexamic acid: a case report. J Med Case Rep 2020;14:212. [PMID: 33158458 DOI: 10.1186/s13256-020-02545-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Poeran J, Chan JJ, Zubizarreta N, Mazumdar M, Galatz LM, Moucha CS. Safety of Tranexamic Acid in Hip and Knee Arthroplasty in High-risk Patients. Anesthesiology 2021;135:57-68. [PMID: 33857300 DOI: 10.1097/ALN.0000000000003772] [Reference Citation Analysis]
7 Dunn LK, Chen CJ, Taylor DG, Esfahani K, Brenner B, Luo C, Buell TJ, Spangler SN, Buchholz AL, Smith JS, Shaffrey CI, Nemergut EC, Durieux ME, Naik BI. Postoperative Low-Dose Tranexamic Acid After Major Spine Surgery: A Matched Cohort Analysis. Neurospine 2020;17:888-95. [PMID: 33401867 DOI: 10.14245/ns.2040114.057] [Reference Citation Analysis]
8 Koh A, Adiamah A, Gomez D, Sanyal S. Safety and efficacy of tranexamic acid in minimizing perioperative bleeding in extrahepatic abdominal surgery: meta-analysis. BJS Open 2021;5:zrab004. [PMID: 33839754 DOI: 10.1093/bjsopen/zrab004] [Reference Citation Analysis]
9 Assi H, Massé V, Saint-Yves H, Barry J, St-Louis J, Isler M. Bilateral Pseudoarthrodesis: A Case Report of Complex Bilateral Total Knee Replacement for a Severe Hemophilia A Patient with Inhibitors. JBJS Case Connect 2022;12. [PMID: 35239593 DOI: 10.2106/JBJS.CC.21.00485] [Reference Citation Analysis]
10 Fowler H, Law J, Tham SM, Gunaravi SA, Houghton N, Clifford RE, Fok M, Barker JA, Vimalachandran D. Impact on blood loss and transfusion rates following administration of tranexamic acid in major oncological abdominal and pelvic surgery: A systematic review and meta-analysis. J Surg Oncol 2022. [PMID: 35471705 DOI: 10.1002/jso.26900] [Reference Citation Analysis]
11 Li S, Yan X, Li R, Zhang X, Ma T, Zeng M, Dong J, Wang J, Liu X, Peng Y. Safety of intravenous tranexamic acid in patients undergoing supratentorial meningiomas resection: protocol for a randomised, parallel-group, placebo control, non-inferiority trial. BMJ Open 2022;12:e052095. [PMID: 35110315 DOI: 10.1136/bmjopen-2021-052095] [Reference Citation Analysis]
12 Houston BL, Fergusson DA, Falk J, Krupka E, Perelman I, Breau RH, McIsaac DI, Rimmer E, Houston DS, Garland A, Ariano RE, Tinmouth A, Balshaw R, Turgeon AF, Jacobsohn E, Zarychanski R. Prophylactic tranexamic acid use in non-cardiac surgeries at high risk for transfusion. Transfus Med 2021;31:236-42. [PMID: 33938051 DOI: 10.1111/tme.12780] [Reference Citation Analysis]
13 Kammerer T, Groene P, Sappel SR, Peterss S, Sa PA, Saller T, Giebl A, Scheiermann P, Hagl C, Schäfer ST. Functional Testing for Tranexamic Acid Duration of Action Using Modified Viscoelastometry. Transfus Med Hemother 2021;48:109-17. [PMID: 33976611 DOI: 10.1159/000511230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Li M, van Raath MI, Khakpour S, Seçilir A, Sliggers BC, Huang X, Ding B, Storm G, van der Hulst RR, de Kroon AIPM, Heger M. In Vivo Assessment of Thermosensitive Liposomes for the Treatment of Port Wine Stains by Antifibrinolytic Site-Specific Pharmaco-Laser Therapy. Pharmaceutics 2020;12:E591. [PMID: 32630457 DOI: 10.3390/pharmaceutics12060591] [Reference Citation Analysis]
15 Lasocki S, Loupec T, Parot-Schinkel E, Vielle B, Danguy des Déserts M, Roquilly A, Lahlou-Casulli M, Collange V, Desebbe O, Duchalais A, Drugeon B, Bouzat P, Garrigue D, Mounet B, Hamard F, David JS, Leger M, Rineau E; HiFIT Study Group. Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study). BMJ Open 2021;11:e040273. [PMID: 33455926 DOI: 10.1136/bmjopen-2020-040273] [Reference Citation Analysis]